Laura Sun

机构：Emory University, Viva Biotech (China) · ORCID：0000-0001-5226-1817

发表论文 24 篇 · 总被引 141 次 · h-index 9

代表论文

• Effect of SLCO1B1 T521C on Statin‐Related Myotoxicity With Use of Lovastatin and Atorvastatin (2021 · Clinical Pharmacology & Therapeutics · 被引 26)
• Abstract C033: HPN328: An anti-DLL3 T cell engager for treatment of small cell lung cancer (2019 · Molecular Cancer Therapeutics · 被引 14)
• Exposure-Response Analyses Indicate a Promising Benefit/Risk Profile of Mosunetuzumab in Relapsed and Refractory Non-Hodgkin Lymphoma (2019 · Blood · 被引 14)
• The Development and Application of Bispecific Antibodies in B-Cell Non-Hodgkin Lymphoma (2025 · Journal of Personalized Medicine · 被引 12)
• Impact of Black Race on Peripheral Neuropathy in Patients With Newly Diagnosed Multiple Myeloma Receiving Bortezomib Induction (2023 · JCO Oncology Practice · 被引 12)
• Nonclinical Pharmacokinetics and Pharmacodynamics Characterization of Anti-CD79b/CD3 T Cell-Dependent Bispecific Antibody Using a Surrogate Molecule: A Potential Therapeutic Agent for B Cell Malignancies (2022 · Pharmaceutics · 被引 12)